跳至主要内容
临床试验/KCT0000801
KCT0000801招募中未知

A Comparison of LY2605541 versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Naive Patients with Type 2 Diabetes Mellitus not Adequately Controlled with 2 or more Oral Antihyperglycemic Medications: An Open-Label,Randomized Study The IMAGINE 6 Study

Eli Lilly Korea0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients with T2DM who are 18 years or older,
  • treated with at least 2 OAMs for at least 3 months prior to the study and who are insulin naive and have a baseline
  • HbA1c of 7.0% to 11.0% as determined by the central laboratory at Visit 1 are eligible for this study.

排除标准

  • should not have used insulin therapy in the past 2 years and should not have been treated with glucagon-like
  • peptide-1 (GLP-1) receptor agonist, rosiglitazone, pramlintide, or weight-loss medication within 3 months of Visit
  • 1. Patients using DPP-IV inhibitors that are approved for use in combination with insulin are allowed to participate
  • in the study. Patients using pioglitazone may be allowed to participate depending on restrictions for use in
  • combination with insulin or metformin described in the local label. Patients should not have had any episodes of
  • severe hypoglycemia, diabetic ketoacidosis, or hyperosmolar state/coma within 6 months prior to Visit 1.

研究者

发起方
Eli Lilly Korea

相似试验

进行中(未招募)
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes Mellitus
EUCTR2012-003941-13-DEEli Lilly and Company630
进行中(未招募)
1 期
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 16.0Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes Mellitus
EUCTR2012-003941-13-CZEli Lilly and Company630
进行中(未招募)
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 16.0Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes Mellitus
EUCTR2012-003941-13-PLEli Lilly and Company630
进行中(未招募)
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 15.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes Mellitus
EUCTR2012-003941-13-ESilly S.A.630
进行中(未招募)
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesType 2 Diabetes MellitusMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861
EUCTR2012-003941-13-HUEli Lilly and Company630